Investor · Hayward, CA
John Bykowski
Open John in the network graph →Capital
$786K
across filings
Active
Apr 2014
to Feb 2020
Most-connected co-filers (43)
Kevin Cavenaugh · Portland, OR6 sharedSandeep Laumas · Raleigh, NC6 sharedJay P. Madan · Raleigh, NC6 sharedScott Zeilinger · New York, NY6 sharedLorne Thomas · Odessa, FL6 sharedKeith Becker · Hayward, CA5 sharedSaira K. Ramasastry · Raleigh, NC4 sharedArnar Agnarsson · Bozeman, MT4 sharedJeffrey Myers · New York, NY4 sharedRuan Van Vuuren · Grand Cayman, Cayman Islands4 sharedRoy K. Proujansky · Raleigh, NC4 sharedLorin K. Johnson · Raleigh, NC4 sharedCampbell Congdon · Grand Cayman, Cayman Islands4 sharedChristopher D. Long · Mission Woods, KS4 sharedWilliam P. Corry · Vero Beach, FL4 sharedShinji Kim · SAN FRANCISCO, CA3 sharedMichael Catalano · San Francisco, CA3 sharedDennis Rapoport · Hayward, CA3 sharedAnthony Maida · Raleigh, NC3 sharedSteve Laski · St George, UT3 sharedGeoff Thompson · Oakland, CA3 sharedRichard Dibiase · Lake Mary, FL3 sharedRosa K. Hooper · Birmingham, AL3 sharedCharles K. Lambert · Birmingham, AL3 shared Recent filings (13)
Fourandhalf, Inc.Feb 2020 · 14 co-filers$175KINNOVATE BIOPHARMACEUTICALS, INC.Jan 2020 · 19 co-filers$2.8MFourandhalf, Inc.Oct 2019 · 14 co-filers$200KINNOVATE BIOPHARMACEUTICALS, INC.May 2019 · 16 co-filers$487KINNOVATE BIOPHARMACEUTICALS, INC.May 2019 · 17 co-filers$8.7MINNOVATE BIOPHARMACEUTICALS, INC.Mar 2019 · 17 co-filers$5.5MFourandhalf, Inc.Apr 2018 · 13 co-filers$486KInnovate Biopharmaceuticals Inc.Dec 2017 · 7 co-filers$2.0MOne4All, Inc.May 2017 · 7 co-filers$1.0MInnovate Biopharmaceuticals Inc.May 2017 · 5 co-filers$5.0MFourandhalf, Inc.Jan 2015 · 7 co-filers$400KFourandhalf, Inc.Jan 2015 · 7 co-filers$400KOne4All, Inc.Apr 2014 · 3 co-filers$1.8MFourandhalf, Inc.Jan 2013 · 4 co-filers$120K Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See John in the interactive graph →